Albany, New York, May 4, 2018: A new research study titled “Swine Respiratory Diseases Treatment Market: Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027” has been added to the vast repository of Market Research Reports Search Engine (MRRSE). According to the research study, the global swine respiratory diseases treatment market is likely to reach a valuation of US$ 2.7 Bn by the end of the assessment period. The market is likely to grow at a CAGR of 6.6% through 2027.
The research study offers in-depth analysis and insights on the swine respiratory diseases treatment market. The market has been studied across key regions and an in-depth analysis on the drug pipeline, novel therapeutic interventions, and competitive landscape in the market has been included for the perusal of the readers. Stakeholders can expect holistic and comprehensive insights on the global swine respiratory disease treatment in the report.
In a bid to offer readers detailed insights on the swine respiratory diseases treatment market, the study offers segment-wise analysis and insights. The segmentation and forecast has been offered on the basis of causative agent, treatment type, route of administration, distribution channel, and region. By causative agent, mycoplasma and virus segment remained most promising, whereas oral route of administration remained the most preferred among end-users.
By treatment type, demand for drugs is likely to reach a valuation of over US$ 1.7 Bn by the end of the forecast period. Although drugs will account for the leading revenue share of the company, demand for vaccines is likely to grow at a brisk pace during the assessment period.
Veterinary hospitals remain the leading distribution channels in the swine respiratory disease treatment market. This segment is likely to reach a valuation of nearly US$ 990 Mn by the end of 2027. Demand is also projected to witness an increase in the pharmacies segment during the assessment period.
The research study also offers in-depth analysis and insights on the global swine respiratory disease treatment market. Asia Pacific excluding Japan (APEJ) is likely to remain one of the leading markets for swine respiratory disease treatment market. The demand for swine respiratory disease treatment drugs is likely to witness steady growth in China, owing to sustained focus of the government to decrease the prevalence of respiratory diseases.
The research study also offers in-depth analysis and insights on the competitive landscape in the market. According to the research study, leading players in the global swine respiratory disease treatment market are focusing on developing novel procedures and drugs to consolidate their position in the market. Some of the key players in the market include Elanco Animal Health (Sub. Eli Lilly), Bayer AG, Boehringer Ingelheim GmbH, Norbrook, Virbac, Zoetis, Ceva Santé Animale, Intervet Inc., (Sub. Merck & Co. Inc.), Vetoquin.
Browse Full Global Swine Respiratory Diseases Treatment Market Report with TOC : https://www.mrrse.com/swine-respiratory-diseases-treatment-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207